Excipients Market: Global Industry Analysis, Trends, Market Size and
Forecasts up to 2024” report has been added to ResearchAndMarkets.com’s
The report on global pharmaceutical excipients market provides
qualitative and quantitative analysis for the period of 2016 to 2024.
The report predicts the global pharmaceutical excipients market to grow
with a CAGR of 5.5% over the forecast period of 2018-2024. The study on
pharmaceutical excipients market covers the analysis of the leading
geographies such as North America, Europe, Asia-Pacific and RoW for the
period of 2016 to 2024.
The report on pharmaceutical excipients market is a comprehensive study
and presentation of drivers, restraints, opportunities, demand factors,
market size, forecasts, and trends in the global pharmaceutical
excipients market over the period of 2016 to 2024. Moreover, the report
is collective presentation of primary and secondary research findings.
The top 5 most relevant categories of excipient are coatings, acids,
solvents, binders and emulsifiers. Coating and binders are commonly used
in oral solid dosage form such as tablets and capsules, while solvents,
emulsifiers and buffers are prevalent in topical products.
Thus increasing demand for functional excipients coupled with growth in
pharmaceutical industry to drive the pharmaceutical excipients market.
However stringent government regulations and lengthy FDA process
approvals are likely to affect the growth of the pharmaceutical
excipients market. Continuous research and development activities in
developing new excipients functionalities and enhancing existing
excipient functionalities will further help to create future growth
Europe held the largest market share of the pharmaceutical excipients
market in 2017, followed by North America. Europe accounted for highest
market share owing to the presence of well-established pharmaceutical
companies such as Novartis and Roche, whose large production capacities
lead to high quantity of excipient consumption.
Asia pacific is expected to grow at the highest CAGR during the forecast
period on account of improving healthcare infrastructure coupled with
increase in the penetration of health care insurance in Asia pacific
For more information about this report visit https://www.researchandmarkets.com/research/j7342l/global?w=44
View source version on businesswire.com: https://www.businesswire.com/news/home/20180713005432/en/